BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 32309427)

  • 21. Clear Cell Renal Cell Carcinoma: A Comprehensive in silico Study in Searching for Therapeutic Targets.
    Naghdibadi M; Momeni M; Yavari P; Gholaminejad A; Roointan A
    Kidney Blood Press Res; 2023; 48(1):135-150. PubMed ID: 36854280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of TYROBP and FCER1G as Key Genes with Prognostic Value in Clear Cell Renal Cell Carcinoma by Bioinformatics Analysis.
    Wang L; Lin Y; Yuan Y; Liu F; Sun K
    Biochem Genet; 2021 Oct; 59(5):1278-1294. PubMed ID: 33786672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New mechanistic insights of clear cell renal cell carcinoma from integrated miRNA and mRNA expression profiling studies.
    Qi Y; Wang L; Wang K; Peng Z; Ma Y; Zheng Z; Shang D; Xu W; Zheng J
    Biomed Pharmacother; 2019 Mar; 111():821-834. PubMed ID: 30616081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of biomarkers of clear cell renal cell carcinoma by bioinformatics analysis.
    Zhang N; Chen W; Gan Z; Abudurexiti A; Hu X; Sang W
    Medicine (Baltimore); 2020 May; 99(21):e20470. PubMed ID: 32481352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinoma.
    Glaser ZA; Love HD; Guo S; Gellert L; Chang SS; Herrell SD; Barocas DA; Penson DF; Cookson MS; Clark PE
    Urol Oncol; 2017 May; 35(5):286-293. PubMed ID: 28108243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 44-gene set constructed for predicting the prognosis of clear cell renal cell carcinoma.
    Wang Y; Wang Y; Liu F
    Int J Mol Med; 2018 Dec; 42(6):3105-3114. PubMed ID: 30272265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three novel hub genes and their clinical significance in clear cell renal cell carcinoma.
    Xiao H; Chen P; Zeng G; Xu D; Wang X; Zhang X
    J Cancer; 2019; 10(27):6779-6791. PubMed ID: 31839812
    [No Abstract]   [Full Text] [Related]  

  • 29. Identification of the key genes and pathways involved in the tumorigenesis and prognosis of kidney renal clear cell carcinoma.
    Cui H; Shan H; Miao MZ; Jiang Z; Meng Y; Chen R; Zhang L; Liu Y
    Sci Rep; 2020 Mar; 10(1):4271. PubMed ID: 32144299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of potential key genes and key pathways related to clear cell renal cell carcinoma through bioinformatics analysis.
    Zhai W; Lu H; Dong S; Fang J; Yu Z
    Acta Biochim Biophys Sin (Shanghai); 2020 Aug; 52(8):853-863. PubMed ID: 32556097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of Differentially Methylated Genes Associated with Clear Cell Renal Cell Carcinoma and Their Prognostic Values.
    Wan B; Yang Y; Zhang Z
    J Environ Public Health; 2023; 2023():8405945. PubMed ID: 36793506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioinformatics Analysis Suggests the Combined Expression of AURKB and KIF18B Being an Important Event in the Development of Clear Cell Renal Cell Carcinoma.
    Liu Q; Zhang X; Tang H; Liu J; Fu C; Sun M; Zhao L; Wei M; Yu Z; Wang P
    Pathol Oncol Res; 2020 Jul; 26(3):1583-1594. PubMed ID: 31489573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Novel Genes and Associated Drugs in Advanced Clear Cell Renal Cell Carcinoma by Bioinformatic Methods.
    Lu M; Xiao L; Xu B; Gao Q
    Tohoku J Exp Med; 2022 Aug; 258(2):79-90. PubMed ID: 35896362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of genes of prognostic value in the ccRCC microenvironment from TCGA database.
    Wan B; Liu B; Huang Y; Lv C
    Mol Genet Genomic Med; 2020 Apr; 8(4):e1159. PubMed ID: 32012488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identifying hub genes of clear cell renal cell carcinoma associated with the proportion of regulatory T cells by weighted gene co-expression network analysis.
    Chen YH; Chen SH; Hou J; Ke ZB; Wu YP; Lin TT; Wei Y; Xue XY; Zheng QS; Huang JB; Xu N
    Aging (Albany NY); 2019 Oct; 11(21):9478-9491. PubMed ID: 31672930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring the mechanism of clear cell renal cell carcinoma metastasis and key genes based on multi-tool joint analysis.
    Yang H; Li W; Lv Y; Fan Q; Mao X; Long T; Xie L; Dong C; Yang R; Zhang H
    Gene; 2019 Dec; 720():144103. PubMed ID: 31491435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioinformatics analysis and verification of gene targets for renal clear cell carcinoma.
    Li F; Jin Y; Pei X; Guo P; Dong K; Wang H; Chen Y; Guo P; Meng LB; Wang Z
    Comput Biol Chem; 2021 Jun; 92():107453. PubMed ID: 33636636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of Hub Genes Associated With Clear Cell Renal Cell Carcinoma by Integrated Bioinformatics Analysis.
    Huang H; Zhu L; Huang C; Dong Y; Fan L; Tao L; Peng Z; Xiang R
    Front Oncol; 2021; 11():726655. PubMed ID: 34660292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrative analysis of protein-coding and non-coding RNAs identifies clinically relevant subtypes of clear cell renal cell carcinoma.
    Li Z; Chen Y; Hu S; Zhang J; Wu J; Ren W; Shao N; Ying X
    Oncotarget; 2016 Dec; 7(50):82671-82685. PubMed ID: 27705920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identifying biomarkers of papillary renal cell carcinoma associated with pathological stage by weighted gene co-expression network analysis.
    He Z; Sun M; Ke Y; Lin R; Xiao Y; Zhou S; Zhao H; Wang Y; Zhou F; Zhou Y
    Oncotarget; 2017 Apr; 8(17):27904-27914. PubMed ID: 28427189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.